Gene Activation, Apolipoprotein A-I/High Density Lipoprotein, Atherosclerosis Prevention and Longevity
Open Access
- 1 August 1997
- journal article
- review article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 81 (2), 57-64
- https://doi.org/10.1111/j.1600-0773.1997.tb00032.x
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Plasma High-Density Lipoproteins and Liver Lipids and Proteins in ManActa Medica Scandinavica, 2009
- A Prospective, Randomized Trial of Phenytoin in Nonepileptic Subjects With Reduced HDL CholesterolArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed RabbitsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Effects of Phenytoin on Plasma High‐Density Lipoprotein Cholesterol Levels in Men with Low Levels of High‐Density Lipoprotein CholesterolThe Journal of Clinical Pharmacology, 1995
- Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studiesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Regulation of apolipoprotein A-I gene expression by phenobarbital in the human hepatocarcinoma cell line, Hep3BAtherosclerosis, 1994
- Effects of Simvastatin and Pravastatin on 6β-hydroxycortisol Excretion, a Potential Marker of Cytochrome P-450 3APharmacological Research, 1993
- Hypolipidemic Activity in Rodents of Phenobarbital and Related DerivativesArchiv der Pharmazie, 1990
- Basic considerations in the reversal of atherosclerosis: Significance of high-density lipoprotein in stimulating reverse cholesterol transportThe American Journal of Cardiology, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987